Cutaneous adenocystic carcinoma
diseaseOn this page
Also known as adenoid cystic carcinoma of skinadenoid cystic carcinoma of the skinadenoid cystic cutaneous carcinomaadenoid cystic eccrine carcinoma (morphologic abnormality)adenoid cystic skin carcinomaprimary cutaneous adenocystic carcinomaskin of body adenoid cystic carcinoma
Summary
Cutaneous adenocystic carcinoma (MONDO:0003180) is a cancer. A subtype of adenoid cystic carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | cutaneous adenocystic carcinoma |
| Mondo ID | MONDO:0003180 |
| DOID | DOID:4871 |
| NCIT | C4471 |
| SNOMED CT | 254711000 |
| UMLS | C0346017 |
| MedGen | 91071 |
| GARD | 0023400 |
| Anatomy (UBERON) | UBERON:0002097 |
| Is cancer (heuristic) | yes |
Also known as: adenoid cystic carcinoma of skin · adenoid cystic carcinoma of the skin · adenoid cystic cutaneous carcinoma · adenoid cystic eccrine carcinoma (morphologic abnormality) · adenoid cystic skin carcinoma · primary cutaneous adenocystic carcinoma · skin of body adenoid cystic carcinoma
Disease family
This is a subtype of adenoid cystic carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › adenoid cystic carcinoma › cutaneous adenocystic carcinoma
Related subtypes (16): lymph node adenoid cystic carcinoma, salivary gland adenoid cystic carcinoma, prostate adenoid cystic carcinoma, lung adenoid cystic carcinoma, adenoid cystic breast carcinoma, esophageal adenoid cystic carcinoma, Bartholin gland adenoid cystic carcinoma, cervical adenoid cystic carcinoma, lacrimal gland adenoid cystic carcinoma, laryngeal adenoid cystic carcinoma, paranasal sinus adenoid cystic carcinoma, pharyngeal adenoid cystic carcinoma, tracheal adenoid cystic carcinoma, vaginal adenoid cystic carcinoma, adenoid cystic carcinoma of the corpus uteri, adenoid cystic carcinoma of oropharynx
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.